Interview with Murtaza Khorakiwala, Managing Director, Wockhardt
You joined Wockhardt in 2000; you became a member of the board in 2006, and were appointed managing director in 2009. The Indian industry has undergone many changes in the…
LSSSDC, established by and for the Life Sciences Sector in India, will serve to address skill gaps across functional areas and levels in the Sector, by helping to generate a sustained stream of high quality skilled individuals, approx. 2.1 million in number— over 10 years. This will help in ensuring growth and competitiveness of the Sector, whilst giving these individuals access to gainful employment in this space.
Contact:
Address: # 14,Palam Marg,Rear 2nd Floor, Vasant Vihar, New Delhi-110057
Website: http://www.lsssdc.in
Email: ranjit.madan@lsssdc.in
You joined Wockhardt in 2000; you became a member of the board in 2006, and were appointed managing director in 2009. The Indian industry has undergone many changes in the…
Glenmark may be poised to release India’s first novel drug, from the in-licensed, anti-diarrheal molecule Crofelemer. Crofelemer has successfully complete Phase III trials, and you are readying to release it…
Since we last met in 2006, the Indian pharmaceutical industry has been doing very well indeed, as a very large number of drugs came off patent. This trend will continue…
Since we last met in 2006, the Indian pharmaceutical industry has been doing very well indeed, as a very large number of drugs came off patent. This trend will continue…
Our last report on India dates back to 2006, right after the Patent Law was passed. What developments have you seen happening in the industry since then? There has been…
“India, as a manufacturing hub, offers safe, effective, quality medicines, at the very best prices. Now, we are on our way to become a R&D hub.” For Dilip Shah, General…
See our Cookie Privacy Policy Here
